Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study

被引:8
|
作者
Alonso-Canovas, Araceli [1 ,2 ]
Kurtis, Monica M. [3 ]
Gomez-Mayordomo, Victor [4 ]
Macias-Garcia, Daniel [5 ,6 ]
Viedma, Alvaro Gutierrez [7 ]
Rezola, Elisabet Mondragon [8 ]
Pagonabarraga, Javier [9 ,10 ]
Orgaz, Lidia Aranzabal [11 ]
Masjuan, Jaime [1 ,2 ]
Martinez-Castrillo, Juan Carlos [1 ,2 ]
Parees, Isabel [2 ,3 ]
机构
[1] Univ Alcala, Med Dept, Madrid, Spain
[2] Hosp Univ Ramon & Cajal, Neurol Dept, Movement Disorders Unit, IRYCIS, Madrid, Spain
[3] Hosp Ruber Int, Neurol Dept, Funct Movement Disorders Unit, Madrid, Spain
[4] Vithas Hosp Grp, Inst Neurosci, Dept Neurol, Madrid, Spain
[5] CIBERNED, Madrid, Spain
[6] Univ Seville, Hosp Univ Virgen Rocio, Neurol & Neurophysiol Dept, Movement Disorders Unit,Inst Biomed Sevilla,CSIC, Seville, Spain
[7] Hosp Univ Fdn Jimenez Diaz, Neurol Dept, Funct Disorders Unit, Madrid, Spain
[8] Hosp Univ Donostia, Dept Neurol, Inst Invest Sanitaria Biodonostia, San Sebastian, Spain
[9] Univ Autonoma Barcelona UAB, Hosp St Pau, Neurol Dept, Movement Disorders Unit, Barcelona, Spain
[10] St Pau Inst Biomed Res IIB St Pau, Barcelona, Spain
[11] Hosp Univ Ramon & Cajal, Internal Med Dept, Madrid, Spain
关键词
COVID-19; CONVERSION DISORDER; FUNCTIONAL NEUROLOGICAL DISORDER;
D O I
10.1136/jnnp-2022-330885
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:776 / 777
页数:2
相关论文
共 50 条
  • [31] Immunogenicity of COVID-19 vaccines and levels of SARS-CoV-2 neutralising antibody in the Bruneian population: Protocol for a national longitudinal study
    Ghani, Hazim
    Ahmad, Liyana
    Sharif, Hanisah
    Wong, Justin
    Bagol, Saifuddien
    Alikhan, Mohammad Fathi
    Taib, Surita
    Tan, Chee Wah
    Zhu, Feng
    Ong, Xin Mei
    Shim, Chin Yee
    Wang, Yan
    Chan, Si Yee
    Wei, Yuan
    Idris, Fazean
    Naing, Lin
    Wang, Lin-Fa
    Cunningham, Anne Catherine
    BMJ OPEN, 2022, 12 (12):
  • [32] SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study
    Nersesjan, Vardan
    Amiri, Moshgan
    Nilsson, Anna Christine
    Wamberg, Christian
    Jensen, Veronika Vorobieva Solholm
    Petersen, Charlotte Bjerg
    Hejl, Anne-Mette
    Lebech, Anne-Mette
    Theut, Anna Marie
    Jorgensen, Charlotte Svaerke
    Blaabjerg, Morten
    Benros, Michael E.
    Kondziella, Daniel
    BRAIN COMMUNICATIONS, 2023, 5 (05)
  • [33] Breakthrough SARS-CoV-2 infections after COVID-19 immunization
    Hirsh, Joshua
    Htay, Thwe
    Bhalla, Shubhang
    Nguyen, Victoria
    Cervantes, Jorge
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (06) : 1429 - 1432
  • [34] Neurological Manifestations of SARS-CoV-2 Infection: Protocol for a Sub-analysis of the COVID-19 Critical Care Consortium Observational Study
    Battaglini, Denise
    Premraj, Lavienraj
    Griffee, Matthew
    Huth, Samuel
    Fanning, Jonathon
    Whitman, Glenn
    Bastos Porto, Diego
    Arora, Rakesh
    Durham, Lucian
    Gnall, Eric
    Amato, Marcelo
    Williams, Virginie
    Noel, Alexandre
    De Franca, Sabrina Araujo
    Samoukovic, Gordan
    Pujo, Bambang
    Kent, David
    Marwali, Eva
    Al-Fares, Abdulrahman
    Stecher, Stephanie-Susanne
    Panigada, Mauro
    Giani, Marco
    Foti, Giuseppe
    Pelosi, Paolo
    Pesenti, Antonio
    White, Nicole Marie
    Li Bassi, Gianluigi
    Suen, Jacky
    Fraser, John F.
    Robba, Chiara
    Cho, Sung-Min
    FRONTIERS IN MEDICINE, 2022, 9
  • [35] Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
    Fernandes, Queenie
    Inchakalody, Varghese Philipose
    Merhi, Maysaloun
    Mestiri, Sarra
    Taib, Nassiba
    El-Ella, Dina Moustafa Abo
    Bedhiafi, Takwa
    Raza, Afsheen
    Al-Zaidan, Lobna
    Mohsen, Mona O.
    Al-Nesf, Mariam Ali Yousuf
    Hssain, Ali Ait
    Yassine, Hadi Mohamad
    Bachmann, Martin F.
    Uddin, Shahab
    Dermime, Said
    ANNALS OF MEDICINE, 2022, 54 (01) : 524 - 540
  • [36] A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
    Funk, Colin D.
    Laferriere, Craig
    Ardakani, Ali
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [37] COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
    Raman, Renuka
    Patel, Krishna J.
    Ranjan, Kishu
    BIOMOLECULES, 2021, 11 (07)
  • [38] Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
    Chavda, Vivek P.
    Vora, Lalitkumar K.
    Pandya, Anjali K.
    Patravale, Vandana B.
    DRUG DISCOVERY TODAY, 2021, 26 (11) : 2619 - 2636
  • [39] SARS-CoV-2 (COVID-19) as a possible risk factor for neurodevelopmental disorders
    Dubey, Harikesh
    Sharma, Ravindra K. K.
    Krishnan, Suraj
    Knickmeyer, Rebecca
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [40] SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
    Uddin, Mohammed
    Mustafa, Farah
    Rizvi, Tahir A.
    Loney, Tom
    Al Suwaidi, Hanan
    Al-Marzouqi, Ahmed H. Hassan
    Eldin, Afaf Kamal
    Alsabeeha, Nabeel
    Adrian, Thomas E.
    Stefanini, Cesare
    Nowotny, Norbert
    Alsheikh-Ali, Alawi
    Senok, Abiola C.
    VIRUSES-BASEL, 2020, 12 (05):